Cargando…
The MHC Associated Peptide Proteomics assay is a useful tool for the non-clinical assessment of immunogenicity
The propensity of therapeutic proteins to elicit an immune response, poses a significant challenge in clinical development and safety of the patients. Assessment of immunogenicity is crucial to predict potential adverse events and design safer biologics. In this study, we employed MHC Associated Pep...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616951/ https://www.ncbi.nlm.nih.gov/pubmed/37915568 http://dx.doi.org/10.3389/fimmu.2023.1271120 |